Lumos Files Appeal To The FDA For FebriDx
Filed with ASX · · 2 pages · English
Watch Lumos Diagnostics' latest callLumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call · Replay · Apr 20Read the transcript of Lumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings CallLumos Diagnostics Holdings Ltd. on 6ix
Story so far
Earlier from Lumos Diagnostics
- Lumos To Close Sarasota Facility
- Reinstatement to Official Quotation
- FDA Decision for FebriDx
- Voluntary Suspension
- Security Class Reinstatement of Quotation LDXO
Later from Lumos Diagnostics
- Lumos Withdraws from Local Manufacturing Proposal
- Lumos Pilot Manufacturing to Commence in Carlsbad
- FY22 Appendix 4E
- FY22 Annual Report
- FY22 Full Year Results Investor Presentation
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics